80 related articles for article (PubMed ID: 33464167)
1. Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma.
Su N; Fang Y; Chen X; Chen X; Xia Z; Huang H; Xia Y; Liu P; Tian X; Cai Q
Blood Sci; 2023 Oct; 5(4):249-257. PubMed ID: 37941919
[TBL] [Abstract][Full Text] [Related]
2. Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion.
Najahi-Missaoui W; Quach ND; Jenkins A; Dabke I; Somanath PR; Cummings BS
Pharmacol Res Perspect; 2019 Oct; 7(5):e00518. PubMed ID: 31516713
[TBL] [Abstract][Full Text] [Related]
3. Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer.
Somanath PR; Chernoff J; Cummings BS; Prasad SM; Homan HD
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190165
[TBL] [Abstract][Full Text] [Related]
4. Recent advances on development of p21-activated kinase 4 inhibitors as anti-tumor agents.
Li Y; Lu Q; Xie C; Yu Y; Zhang A
Front Pharmacol; 2022; 13():956220. PubMed ID: 36105226
[TBL] [Abstract][Full Text] [Related]
5. P21-activated kinase in inflammatory and cardiovascular disease.
Taglieri DM; Ushio-Fukai M; Monasky MM
Cell Signal; 2014 Sep; 26(9):2060-9. PubMed ID: 24794532
[TBL] [Abstract][Full Text] [Related]
6. Cytostatic p21 G protein-activated protein kinase gamma-PAK.
Roig J; Traugh JA
Vitam Horm; 2001; 62():167-98. PubMed ID: 11345898
[TBL] [Abstract][Full Text] [Related]
7. Group I p21-activated kinases in leukemia cell adhesion to fibronectin.
Kuželová K; Obr A; Röselová P; Grebeňová D; Otevřelová P; Brodská B; Holoubek A
Cell Adh Migr; 2021 Dec; 15(1):18-36. PubMed ID: 33464167
[TBL] [Abstract][Full Text] [Related]
8. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
[TBL] [Abstract][Full Text] [Related]
9. PAK1 and PAK2 in cell metabolism regulation.
Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
[TBL] [Abstract][Full Text] [Related]
10. Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells.
Kuželová K; Grebeňová D; Holoubek A; Röselová P; Obr A
PLoS One; 2014; 9(3):e92560. PubMed ID: 24664099
[TBL] [Abstract][Full Text] [Related]
11. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
12. The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.
Nuche-Berenguer B; Ramos-Álvarez I; Jensen RT
Biochim Biophys Acta; 2016 Jun; 1862(6):1122-36. PubMed ID: 26912410
[TBL] [Abstract][Full Text] [Related]
13. Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations.
Kuželová K; Obr A; Marková J; Gašová Z
Eur J Haematol; 2020 Nov; 105(5):578-587. PubMed ID: 32668024
[TBL] [Abstract][Full Text] [Related]
14. Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.
Han D; Wang H; Cui W; Zhang B; Chen BZ
Future Med Chem; 2020 Mar; 12(5):367-385. PubMed ID: 32064922
[No Abstract] [Full Text] [Related]
15. Effect of PAK Inhibition on Cell Mechanics Depends on Rac1.
Mierke CT; Puder S; Aermes C; Fischer T; Kunschmann T
Front Cell Dev Biol; 2020; 8():13. PubMed ID: 32047750
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
